Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrzej Kaszuba is active.

Publication


Featured researches published by Andrzej Kaszuba.


Journal of The European Academy of Dermatology and Venereology | 2015

Impact of psoriasis severity on family income and quality of life

Tomasz Hawro; Anna Zalewska; M. Hawro; Andrzej Kaszuba; M. Królikowska; M. Maurer

Psoriasis is a common disease and the costs of its therapy, medical care and loss of productivity are a major financial burden for patients and society. The financial status of psoriasis patients and its relationship with disease severity and quality of life (QoL) remains ill characterized.


Burns | 2014

The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds

Monika Sienkiewicz; Katarzyna Poznańska-Kurowska; Andrzej Kaszuba; Edward Kowalczyk

Hard-to-heal wounds represent a significant problem to patients, health care professionals, and health care system. They can be formed as a result of mechanical injuries and burns, and any co-existing chronic disease increases the risk of their emergence. Diabetics are at a greater risk of developing chronic wounds because of poor circulation, slow healing times, vascular disease and neuropathy. The aim of this study was to determine the antimicrobial activity of geranium oil against Gram-negative bacterial clinical strains. Clinical strains were isolated from patients with difficult-to-treat wounds and a comprehensive evaluation of their sensitivity to antibiotics was carried out. The constituents of geranium oil were specified by GC-FID-MS analysis. The micro-dilution broth method was used to check the inhibition of microbial growth at various concentrations of geranium oil. The tested geranium oil was efficacious against Gram-negative pathogens responsible for problems with wound treatment. The results suggest that geranium oil may be considered an effective component of therapy in the case of frequent recurrences of infections caused by resistant pathogens.


Journal of The American Academy of Dermatology | 2017

Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis

Marlena Hawro; Marcus Maurer; Karsten Weller; Romuald Maleszka; Anna Zalewska-Janowska; Andrzej Kaszuba; Zofia Gerlicz-Kowalczuk; Tomasz Hawro

Background Psoriasis vulgaris is characterized by disfiguring and stigmatizing skin lesions. The links among lesions distribution, severity, and stigmatization remain unclear. Objective We sought to investigate if the involvement of visible and sensitive areas is linked to stigmatization. Methods In all, 115 patients with psoriasis vulgaris were assessed for disease severity, skin lesions distribution, itch, and stigmatization using the Feelings of Stigmatization Questionnaire. Quality of life was assessed with the Dermatology Life Quality Index and the World Health Organization Quality of Life‐BREF. Results The localization of psoriatic lesions on the back of hands was related to higher stigmatization levels (P = .011, total score of the Feelings of Stigmatization Questionnaire), but not the involvement of nails, the palms, the face, or the genital area nor overall disease severity. All patients reported some level of stigmatization, regardless of the localization of lesions and type of psoriasis. Higher levels of stigmatization characterized patients who claimed not to be able to hide their lesions by clothing (P = .025), women (P = .001), and the unemployed (P = .004). Stigmatization was the strongest predictor of quality of life impairment. Limitations Only hospitalized patients were included. Conclusions Psoriatic lesions on the back of hands are debilitating and warrant effective treatment. Special attention should be paid to female patients, who are more sensitive to stigmatization.


Postepy Dermatologii I Alergologii | 2015

Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis

Katarzyna Tabara; Anna Szewczyk; Wojciech Bienias; Agnieszka Wojciechowska; Marta Pastuszka; Magdalena Oszukowska; Andrzej Kaszuba

Amorolfine 5% and ciclopirox 8% nail lacquers are commonly used in topical treatment of onychomycosis. These formulations may be used alone or in combination with oral antifungal agents. Amorolfine and ciclopirox are valuable therapeutic options, however, their usage in monotherapy should be limited. Proper amorolfine and ciclopirox penetration through the nail plate is provided by transungual drug delivery systems. Although amorolfine and ciclopirox have a different mode of action, they both exhibit a broad antifungal activity. The use of antifungal nail lacquers in combination with oral agents, such as terbinafine and itraconazole, improves efficacy of antifungal therapy.


Postepy Dermatologii I Alergologii | 2015

The effect of clary sage oil on staphylococci responsible for wound infections

Monika Sienkiewicz; Anna Głowacka; Katarzyna Poznańska-Kurowska; Andrzej Kaszuba; Anna Urbaniak; Edward Kowalczyk

Introduction The spreading of bacterial antibiotic resistance among clinical strains of pathogenic bacteria has made investigators to search for other active antibacterial agents which could provide a valuable complement to the existing therapies. Aim To determine the antibacterial activity of clary sage oil (Salvia sclarea L.) against Staphylococcus clinical strains which were isolated from patients with wound infections. Material and methods A comprehensive evaluation of Staphylococcus clinical strain resistance to antibiotics was performed. The constituents of clary sage oil were assayed by GC-FID-MS analysis. The minimal inhibitory concentration (MIC) of the tested essential oil against staphylococci by the micro-dilution broth method was determined. Results The clary sage oil was active against Staphylococcus aureus, S. epidermidis and S. xylosus with MIC values ranging from 3.75 to 7.00 µl/ml. Conclusions The results of the in vitro tests encourage to use formulations containing sage oil as the active natural antimicrobial agent. Because of its antimicrobial properties clary sage oil may be applied to treat wounds and skin infections.


PLOS ONE | 2017

The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci

Bartłomiej Kisiel; Katarzyna Kisiel; Konrad M. Szymanski; Wojciech Mackiewicz; Ewelina Biało-Wójcicka; Sebastian Uczniak; Anna Fogtman; Roksana Iwanicka-Nowicka; Marta Koblowska; Helena Kossowska; Grzegorz Placha; Maciej Sykulski; Artur Bachta; Witold Tłustochowicz; Rafał Płoski; Andrzej Kaszuba

Objectives To confirm the association of previously discovered psoriasis (Ps) risk loci with the disease in a Polish population and to create predictive models based on the combination of these single nucleotide polymorphisms (SNPs). Material and methods Thirty-eight SNPs were genotyped in 480 Ps patients and 490 controls. Alleles distributions were compared between patients and controls, as well as between different Ps sub-phenotypes. The genetic risk score (GRS) was calculated to assess the cumulative risk conferred by multiple loci. Results We confirmed associations of several loci with Ps: HLA-C, REL, IL12B, TRIM39/RPP21, POU5F1, MICA. The analysis of ROC curves showed that GRS combining 16 SNPs at least nominally (uncorrected P<0.05) associated with Ps (GRS-N) had significantly better discriminative power than GRS combining SNPs associated with Ps after the Bonferroni correction (AUC 0.776 vs. 0.750, P = 1 x 10−4) or HLA-C (AUC 0.776 vs. 0.694, P<1 x 10−5). On the other hand, adding additional SNPs to the model did not improve its discriminatory ability (AUC 0.782 for GRS combining all SNPs, P>0.05). In order to assess the total risk conferred by GRS-N, we calculated ORs according to GRS-N quartile ˗ the Ps OR for top vs. bottom GRS-N quartiles was 12.29 (P<1 x 10−6). The analysis of different Ps sub-phenotypes showed an association of GRS-N with age of onset and family history of Ps. Conclusions We confirmed the association of Ps with several previously identified genetic risk factors in a Polish population. We found that a GRS combining 16 SNPs at least nominally associated with Ps had a significantly better discriminatory ability than HLA-C or GRS combining SNPs associated with Ps after the Bonferroni correction. In contrast, adding additional SNPs to GRS did not increase significantly the discriminative power.


Autoimmunity | 2016

Genetic polymorphism of CYP2D6 in patients with systemic lupus erythematosus and systemic sclerosis

Małgorzata Barańska; Mariola Rychlik-Sych; Andrzej Kaszuba; Bożena Dziankowska-Bartkowiak; Jadwiga Skrętkowicz; Elżbieta Waszczykowska

Human organism is constantly exposed to harmful exogenous factors (xenobiotics) including drugs and carcinogenic compounds that can induce development of a large number of diseases. The processes of biotransformation in the organism are multidirectional and xenobiotics can be transformed into active or inactive metabolites via the oxidative route. The knowledge of oxidation polymorphism in the course of systemic lupus erythematosus and systemic sclerosis may be helpful in choosing more efficient and safer therapy, particularly in the case of a disease involving various organs and treated with drugs belonging to diverse therapeutic groups. The aim of the study was to evaluate the CYP2D6 polymorphism in the SLE (systemic lupus erythematosus) and SSc (systemic sclerosis) patients and to investigate a possible correlation with disease susceptibility. The study was carried out in 296 patients: 65 patients with SLE, 81 patients with SSc, and 150 healthy volunteers. The CYP2D6 genotypes were analyzed by polymerase chain reaction fragment length polymorphism (PCR-RFLP) method. The relative risk of developing SSc, expressed by the odds ratio, was three-fold higher for persons with the CYP2D6*1/CYP2D6*4 genotype (OR = 2.9; statistically significant difference, p = 0.0002). A statistically significant correlation between the CYP2D6*4 allele prevalence and the risk for developing SSc was found (OR = 1.53; p = 0.047). No effect of the CYP2D6 gene mutations on the incidence of SLE was noted. The obtained results may suggest the influence of CYP2D6*4 gene variants alleles on increased incidence of systemic sclerosis.


Postepy Dermatologii I Alergologii | 2016

Presence of selected metabolic syndrome components in patients with psoriasis vulgaris

Sebastian Uczniak; Zofia A. Gerlicz; Magdalena Kozłowska; Andrzej Kaszuba

Introduction Recent studies have suggested a strong association between psoriasis and obesity, dyslipidemia, hypertension, resistance to insulin and metabolic syndrome. Aim To assess the prevalence of selected metabolic syndrome components in patients with psoriasis and the effect of the abnormalities on the disease activity. Material and methods Two hundred and forty-six patients diagnosed with psoriasis and 75 healthy individuals as controls were included in the study. Psoriasis activity was evaluated by the Psoriasis Area and Severity Index (PASI). Results There was a statistically significant difference in triglyceride concentration between psoriasis patients and controls (p = 0.00001), which was not found for high-density lipoprotein (HDL) concentration. Mean values of serum glucose level in patients with psoriasis were significantly higher than in controls (p = 0.046). Further statistical analysis of the obtained results showed significantly higher systolic blood pressure in the psoriasis patients than in the controls (p = 0.0001), but there was no statistically significant difference in diastolic blood pressure between the investigated groups (p > 0.05). Conclusions Higher prevalence of metabolic syndrome components was observed in patients with psoriasis than in the general population.


Quantitative InfraRed Thermography | 2015

System and software for thermal images screening in medicine – application to psoriasis

Maria Strakowska; Andrzej Kaszuba; B. Więcek; Michal Strzelecki; Gilbert De Mey

This paper presents a novel method for medical screening of the skin pathology such as melanoma, tumours, different inflammations, psoriasis as well as breast cancers. It is assumed that the presented method can be useful for all diseases where the vascularization could be different for healthy and unhealthy tissues. Our approach uses a 3-layer thermal model of the skin to estimate the time constants and validate the obtained results. The model is tuned by the measured data captured using a thermal camera. Application of the optimization procedure allows the estimation of the thermal parameters for the layers of the skin. These values of the parameters are then used for a classification of the different tissue’s states. System and software are presented as a novel tool which can support a medical screening using a thermovision camera. Validation of the proposed method was performed on psoriasis.


Postepy Dermatologii I Alergologii | 2015

Sturge-Weber syndrome type II treated with PDL 595 nm laser

Joanna Kowalska-Brocka; Maciej Brocki; Sebastian Uczniak; Kamila Uczniak; Andrzej Kaszuba; Piotr Jurowski

Sturge-Weber syndrome (SWS) is rare congenital disorder presenting facial port-wine stains (PWS) eye abnormalities and cerebrovascular malformations. The frequency of SWS is estimated at 1 in 50 000. Cerebrovascular abnormalities can be responsible for seizures, hemiparesis, mental retardation and ophthalmologic abnormalities cause intraocular pressure, glaucoma. Etiopathogenesis of SWS remains elusive. We present a case of a 7-year-old girl with SWS type II. A port-wine stain involves the upper right part of half face and has been associated with glaucoma of both eyes. In the Department of Dermatology in 2009–2012 we performed 23 procedures within 2 months. We have been using PDL laser at wavelength 595 nm and very good cosmetic results were achieved. Given positive treatment effects, the laser therapy of port-wine stains is a method of selection. Port-wine stains in the course of SWS requires a large number of laser treatment.

Collaboration


Dive into the Andrzej Kaszuba's collaboration.

Top Co-Authors

Avatar

Adam Reich

Wrocław Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joanna Maj

University of Wrocław

View shared research outputs
Top Co-Authors

Avatar

Lidia Rudnicka

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar

Joanna Narbutt

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Aleksandra Kaszuba

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Aleksandra Lesiak

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Dorota Krasowska

Medical University of Lublin

View shared research outputs
Top Co-Authors

Avatar

Grażyna Chodorowska

Medical University of Lublin

View shared research outputs
Top Co-Authors

Avatar

Witold Owczarek

United Kingdom Ministry of Defence

View shared research outputs
Researchain Logo
Decentralizing Knowledge